Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Common Stock Issued

Cash raised by issuing new shares.

Organigram Global Inc.NASDAQ: OGI

Common Stock Issued · Q2 FY2026 · quarter ended Mar 2026

Common stock issued turns negative

Q2 FY2026 common stock issued was -CA$51.13K, compared with CA$28.61M a year earlier. Trailing-twelve-month common stock issued was -CA$42.2K.

Context

  • Common stock issued amounted to 15.9% of revenue in FY2025, down 52.0 pp from a year earlier.
  • Common stock issued increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly common stock issued holds near -CA$51.13K or moves back toward the trailing-twelve-month quarterly average of -CA$10.55K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$51.13K-952.9% QoQ
Last fiscal yearSep 2025
CA$29.57M-72.8% YoY
LTMMar 2026
-CA$42.2K-100.0% YoY
Common Stock Issued past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.2%——
1 year-72.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Issued history

CAD · from the cash flow

Latest · FY2025
29.57M CAD
Year-over-year change
-72.8%
4-year CAGR
-43.2%

Common Stock Issued vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock issued is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -100.0% is the lowest of 8, against a peer median of +406.7%.
  • Common stock issued amounts to 0.0% of revenue for OGI, versus a peer median of 20.0%.
OGI Competitors
Common Stock Issued for OGI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HSDTSolana CompanyLTM Mar 2026$443.63M USD+29182.4%+196.8%4626.4%
IVAInventiva S.A.FY2025€237.74M EUR+314.6%+199.8%5303.2%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$77.76M USD+406.7%-13.1%237.6%
RNACCartesian Therapeutics, Inc.LTM Mar 2026$15.81M USD+1996.9%—890.8%
DERMJourney Medical CorporationLTM Mar 2026$12.92M USD+20.9%+392.1%20.0%
ACBAurora Cannabis Inc.LTM Mar 2026CA$9.94M CAD+1112.0%-48.6%3.2%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$360K USD——0.3%
ELMDElectromed, Inc.LTM Mar 2026$112K USD-70.6%—0.2%
OGIOrganigram Global Inc.LTM Mar 2026CA$42.2K CAD-100.0%—0.0%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$8K USD——0.0%
Peer median (excluding OGI) —+406.7%+196.8%20.0%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Depreciation & Amortization31.03M24.91M24.08M12.08M17.98M
Deferred Income Tax42.21M(88K)(2.66M)0(13.77M)
Stock-Based Compensation3.9M5.13M5.29M7.18M4.22M
Change in Working Capital24.2M(22.88M)12.51M14.96M(2.12M)
Accounts Receivables(6.01M)(24.02M)12.51M(12.06M)(15.29M)
Inventory28.68M(12.22M)000
Accounts Payables2.06M12.15M000
Other Working Capital(542K)1.21M(4.06M)27.02M13.16M
Other Non-Cash Items776K(29M)151.8M15.09M14.16M
Operating Cash Flow(28.59M)(36.21M)(35.8M)3.87M(4.3M)
Capital Expenditures(12.33M)(48.78M)(26.9M)(5.34M)(12.22M)
Acquisitions (Net)(2.54M)(11.06M)00(65.62M)
Purchases of Investments(120.02M)(15M)(7.36M)(29.24M)(1.01M)
Sales of Investments50.85M114.59M36.37M3.52M2.5M
Other Investing Activities(31.08M)4.29M31.46M(8.32M)21.8M
Investing Cash Flow(115.11M)44.03M4.56M(38.77M)(59.35M)
Debt Repayment(116.4M)(1.01M)(64.04K)(786K)(43.08K)
Common Stock Issued284.88M6.34M20K108.56M29.57M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities5.99M6.34M(754.15K)6K(1.29M)
Financing Cash Flow174.46M5.33M(754.15K)107.78M28.24M
Effect of Forex Changes0000(2.57M)
Net Change in Cash30.77M13.15M(68.52M)72.88M(37.98M)
Free Cash Flow(40.92M)(84.99M)(62.7M)(1.47M)(16.52M)

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.